RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
FRONTIERS IN ENDOCRINOLOGY
Collezione AOU San Luigi di Orbassano

Items : 6

Are comorbidities of patients with adrenal incidentaloma tied to sex? in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2024 May 14;15:1385808. doi: 10.3389/fendo.2024.1385808. eCollection 20

2024
AOU San Luigi di Orbassano

Puglisi S; Bara? Neki? A; Morelli V; Alessi Y; Fosci M; Pani A; Zibar Tomsic K; Palmieri S; Ferraù F; Pia A; Chiodini I; Kastelan D; Reimondo G; Terzolo M;

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Apr 27;13:899616. doi: 10.3389/fendo.2022.899616. eCollection 2022

2022
AOU San Luigi di Orbassano

Pivonello R; Bancos I; Feelders RA; Kargi AY; Kerr JM; Gordon MB; Mariash CN; Terzolo M; Ellison N; Moraitis AG;

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Jan 4;12:793262. doi: 10.3389/fendo.2021.793262. eCollection 2021.

2021
AOU San Luigi di Orbassano

Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG; Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG;

Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2021 Oct 21;12:738848. doi: 10.3389/fendo.2021.738848. eCollection 2021

2021
AOU San Luigi di Orbassano

Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G;

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2021 Jul 14;12:662865. doi: 10.3389/fendo.2021.662865. eCollection 2021

2021
AOU San Luigi di Orbassano

Pivonello R; Bancos I; Feelders RA; Kargi AY; Kerr JM; Gordon MB; Mariash CN; Terzolo M; Ellison N; Moraitis AG;

Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2020 Nov 30;11:599255. doi: 10.3389/fendo.2020.599255. eCollection 2020

2020
ASL Vercelli
AOU San Luigi di Orbassano

Macaya C; Huang J; Fernandez-Perez C; Rondano E; Abumayyaleh M; D'Ascenzo F; López Pais J; Marin F; Bondia E; Buzón L; Roubin SR; Castro Mejía AF; Alfonso E; Cerrato E; Pepe M; García Aguado M; Molina M; Trabattoni D; Feltes G; Uribarri A; Romero R; Becerra-Muñoz VM; Arroyo-Espliguero R; Maroun-Eid C; Rubio MA; Cuesta M; Núñez-Gil IJ; Ruiz-Sánchez JG; de Miguel Novoa P; et alii...